License & Certificate
Our certifications & licenses
Disease State Source plasma
Our source plasma product licenses
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Toxoplasmosis
- Chagas Disease
- Syphilis
- Lupus
- Rheumatoid Arthritis
- HTLV-I/II
Testing method
Test methodologies
HIV-1/ HIV-2 (rDNA) EIA for the qualitative detection of Antibodies to Human Immunodeficiency virus type 1 and / or type 2.
Chemiluminescent Immunoassay for the qualitative detection of Hepatitis B Surface Antigen.
Chemiluminescent Immunoassay for the qualitative detection of antibody to Hepatitis C virus.
Chemiluminescent Immunoassay for the qualitative detection of antibody to Chagas’ Disease.
Qualitative in vitro nucleic acid amplification test to screen for human immunodeficiency virus type 1 (HIV-1) RNA, hepatitis C virus (HCV) RNA and hepatitis B virus (HBV) DNA in plasma and serum specimens.
Qualitative in vitro nucleic acid assay system for the detection of West Nile Virus (WNV) RNA in plasma specimens.
Qualitative nontreponemal flocculation test for the detection of reagin antibodies.
Investigational qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in plasma specimens.
Investigational qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in plasma specimens.